| Literature DB >> 31717664 |
Yu Kume1, Tomoko Takahashi2, Yuki Itakura3, Sangyoon Lee4, Hyuma Makizako5, Tsuyosi Ono6, Hiroyuki Shimada4, Hidetaka Ota3.
Abstract
A gradually increasing prevalence of mild cognitive impairment (MCI) is recognized in the super-aging society that Japan faces, and early detection and intervention in community-dwellers with MCI are critical issues to prevent dementia. Although many previous studies have revealed MCI/non-MCI differences in older individuals, information on the prevalence and characteristics of MCI in rural older adults is limited. The aim of this study was to investigate differential characteristics between older adults with and without MCI. The investigation was conducted over one year from 2018 to 2019. Participants were recruited from Akita in northern Japan. Neuropsychological assessments were applied to classify MCI, including the National Center for Geriatrics and Gerontology Functional Assessment Tool (NCGG-FAT) and the Touch panel-type Dementia Assessment Scale (TDAS) based on the Alzheimer's disease assessment scale. Our samples consisted of 103 older adults divided into 54 non-MCI and 49 MCI. The MCI group had lower scores of all cognitive items. Our results showed that individuals with MCI had significantly slower walking speed (WS) and worse geriatric depression scale (GDS) compared to non-MCI. In addition, WS was significantly associated with some cognitive items in non-MCI, but not in MCI. Finally, we showed that predictive variables of MCI were WS and GDS. Our study provides important information about MCI in rural community-dwellers. We suggest that older adults living in a super-aging society should receive lower limb training, and avoiding depression in older adults through interaction of community-dwellers may contribute to preventing the onset of MCI.Entities:
Keywords: depression; mild cognitive impairment; older adults living in super-aging society; walking speed
Year: 2019 PMID: 31717664 PMCID: PMC6912714 DOI: 10.3390/jcm8111937
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Characteristics of participants with and without mild cognitive impairment (MCI).
| Variables | Non-MCI Group | MCI Group | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| Age (years) | 74.1 | 6.1 | 74.4 | 5.7 | 0.84 | |
| Gender (% female) | 53.7% | 55.1% | 0.89 | |||
| Height (cm) | 155.0 | 8.2 | 156.0 | 8.5 | 0.53 | |
| Weight (kg) | 57.9 | 11.4 | 60.0 | 10.1 | 0.34 | |
| Body Mass Index (kg/m2) | 24.0 | 3.7 | 24.6 | 3.5 | 0.41 | |
| % | % |
| ||||
| Hypertension (% Yes) | 63.0% | 61.2% | 0.86 | |||
| Diabetes (% Yes) | 20.4% | 26.5% | 0.46 | |||
|
| ||||||
| Frail phenotype (%, robust/pre-frail/frail) | 50%/50%/0% | 43%/47%/10% | 0.054 | |||
| (i) Weight loss (% Yes) | 11.1% | 14.3% | 0.63 | |||
| (ii) Poor energy (% Yes) | 16.7% | 26.5% | 0.22 | |||
| (iii) Low physical activity level (% Yes) | 13.0% | 18.4% | 0.45 | |||
|
|
|
|
|
| ||
| (iv) Grip strength (kg) | 25.2 | 12.0 | 22.9 | 9.0 | 0.25 | |
| (v) Walking speed (m/s) | 1.3 | 0.4 | 1.2 | 0.3 | 0.03 | * |
| Amount of medications ( | 3.0 | 3.0 | 4.0 | 4.0 | 0.17 | |
| Education (years) | 12.0 | 3.0 | 12.0 | 3.0 | 0.18 | |
| GDS-15 total score (score) | 2.0 | 2.0 | 3.0 | 4.0 | 0.046 | * |
|
| ||||||
| Word recognition (score) | 11.7 | 3.8 | 8.0 | 4.2 | 0.000 | *** |
| Tablet version of TMT-A (s) | 19.0 | 6.0 | 27.0 | 11.0 | 0.000 | *** |
| Tablet version of TMT-B (s) | 33.5 | 18.0 | 46.0 | 44.5 | 0.000 | *** |
| Tablet version of SDST (score) | 42.0 | 12.0 | 33.0 | 12.5 | 0.000 | *** |
|
| ||||||
| TDAS total score (score) | 2.0 | 3.0 | 7.0 | 9.0 | 0.000 | *** |
* p < 0.05, ** p < 0.01, *** p < 0.001, Mann–Whitney test was applied for Education (years), Amount of medications (n), GDS-15 total score (score), Grip strength (kg), Walking speed (m/s), and cognitive measurements of NCGG-FAT and TDAS. Age, height, weight, and BMI were analyzed by unpaired t test, and gender (% female), hypertension (% Yes), diabetes (% Yes), weight loss (% Yes), poor energy (% Yes), and low physical activity level (% Yes) were analyzed by chi-squared test, except for Pearson’s chi-square test for frail phenotype (%, robust/pre-frail/frail). SD, standard deviation; IQR, interquartile range; Loss weight, Loss weight more than 3 kg in six months; TMT-A, Trail Making Test A version; TMT-B, Trail Making Test B version; SDST, Symbol Digit Substitution Task; TDAS, Touch Panel-type Dementia Assessment Scale; GDS-15, Geriatric Depression Scale.
Correlations for each group (non-MCI and MCI).
| Variables | Non-MCI Group ( | MCI Group ( | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WS | GS | WR | TMT-A | TMT-B | SDST | TDAS | WS | GS | WR | TMT-A | TMT-B | SDST | TDAS | |
| Age (years) | −0.37 ** | −0.21 | −0.51 ** | 0.55 ** | 0.66 ** | −0.66 ** | 0.05 | −0.37 * | −0.04 | −0.33 * | 0.43 ** | 0.49 ** | −0.47 ** | 0.25 |
| BMI (kg/m2) | 0.08 | 0.24 | 0.18 | 0.05 | 0.05 | 0.02 | 0.00 | −0.19 | 0.08 | 0.19 | 0.01 | −0.01 | 0.03 | −0.04 |
| Education (years) | 0.19 | −0.01 | 0.03 | −0.36 ** | −0.35 ** | 0.15 | −0.13 | −0.02 | 0.28 | 0.09 | −0.13 | −0.10 | 0.29 | −0.45 ** |
| Medications ( | 0.06 | −0.22 | −0.11 | −0.02 | 0.22 | 0.01 | −0.16 | −0.24 | 0.25 | 0.04 | −0.03 | 0.07 | −0.07 | 0.06 |
| WS (m/s) | 1.00 | 0.26 | 0.42 ** | −0.31 ** | −0.35 ** | 0.44 ** | −0.05 | 1.00 | −0.08 | −0.08 | −0.18 | −0.07 | 0.12 | −0.06 |
| GS (kg) | 0.26 | 1.00 | 0.18 | −0.09 | −0.02 | 0.22 | 0.31 * | −0.08 | 1.00 | 0.06 | 0.16 | −0.12 | 0.16 | −0.11 |
| GDS-15 (score) | 0.16 | 0.01 | 0.03 | 0.00 | −0.01 | −0.04 | 0.00 | 0.03 | −0.16 | 0.12 | −0.13 | −0.28 | 0.12 | −0.14 |
* p < 0.05, ** p < 0.01, Statistics represent Spearman r correlations for each parameter. BMI, body mass index; WS, walking speed; GS, grip strength; WR, word recognition; TMT-A, Trail Making Test A version; TMT-B, Trail Making Test B version; SDST, Symbol Digit Substitution Task; TDAS, Touch Panel-type Dementia Assessment Scale; GDS-15, Geriatric Depression Scale-15.
Multiple comparison among binomial logistic regression models depending on MCI classification with odds ratio.
| Model | Coefficient (β) | Odds Ratio | 95% CI | |
|---|---|---|---|---|
|
| ||||
| Age (years) | −0.27 | 0.77 | 0.66, 0.89 | 0.000 |
| TMT-B (s) | 0.08 | 1.09 | 1.04, 1.14 | 0.001 |
| SDST (score) | −0.12 | 0.88 | 0.80, 0.97 | 0.012 |
| TDAS total score (score) | 0.65 | 1.91 | 1.37, 2.68 | 0.000 |
|
| ||||
| Age (years) | −0.26 | 0.77 | 0.67, 0.88 | 0.000 |
| WR (score) | −0.55 | 0.58 | 0.44, 0.76 | 0.000 |
| TMT-A (s) | 0.17 | 1.19 | 1.07, 1.33 | 0.001 |
| TMT-B (s) | 0.05 | 1.05 | 1.01, 1.10 | 0.025 |
| GDS-15 total score (score) | 0.32 | 1.37 | 1.07, 1.77 | 0.014 |
|
| ||||
| Walking speed (m/s) | −2.29 | 0.10 | 0.02, 0.69 | 0.020 |
| GDS-15 total score (score) | 0.20 | 1.22 | 1.04, 1.43 | 0.015 |
Reference group for analysis was non-MCI group. Model I: Model χ2 test, p < 0.0001; The Hosmer–Lemeshow test, p = 0.12; Percentage of correct classifications = 87.4%. Model II: Model χ2 test, p < 0.0001; The Hosmer–Lemeshow test, p = 0.84; Percentage of correct classifications = 84.5%. Model III: Model χ2 test, p = 0.002; The Hosmer–Lemeshow test, p = 0.02; Percentage of correct classifications = 59.2%. CI, confidence interval; WR, word recognition; TMT-A, Trail Making Test A version; TMT-B, Trail Making Test B version; SDST, Symbol Digit Substitution Task; TDAS, Touch Panel-type Dementia Assessment Scale; GDS, Geriatric Depression Scale-15.